Crossmark

Differences in discontinuation of statin treatment in women and men with advanced cancer disease

Crossref DOI link: https://doi.org/10.1186/s13293-018-0207-5

Published Online: 2018-10-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bergström, Helena

Brånvall, Elsa

Helde-Frankling, Maria

Björkhem-Bergman, Linda
Funding

Funding for this research was provided by:

Stockholms Läns Landsting (ALF20160036)

Cancerfonden (CAN 2015/249 and CAN 2017/233)
License Information

Text and Data Mining valid from 2018-10-20
More Information

Article History

Received: 27 August 2018

Accepted: 11 October 2018

First Online: 20 October 2018

Ethics approval and consent to participate

: The study was approved by the local Ethical Committee at Karolinska Institutet (Dnr: 2014/455-31/4 and 2015/776-31) and was performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from all study participants before inclusion.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.